CS
KNTE

Candriam SCA’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Candriam SCA’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-135,298
Closed -$825K – 943
2022
Q4 		$825K Buy
135,298
+68,941
+104% +$421K 0.01% 743
2022
Q3 		$793K Buy
+66,357
New +$793K 0.01% 759